V

Viking Therapeutics
D

VKTX

42.270
USD
0.78
(1.88%)
قبل الجلسة
حجم التداول
769
الربح لكل سهم
-1
العائد الربحي
-
P/E
-45
حجم السوق
4,710,415,952
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    C
    CRBP
    -0.370
    (-2.78%)
    12.960 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    G
    GNFT
    0.00000
    (0.00%)
    3.81000 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Viking Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.